‹ All questions

How is West Pharmaceutical Services (WST) doing?

West Pharmaceutical Services is a company in the medical, instruments & supplies industry, based in Exton, PA, worth $25.8B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.

Updated Oct 9, 2026

27
P3 score

Weak

West Pharmaceutical Services shares are up 37% over the past year, 18 points ahead of the S&P 500. Its type is Hot Hand. Among large US stocks and funds it ranks in the 86th percentile on market beat, the 3rd on staying power and the 80th on business growth. It appears on 5 of our dashboards.

$366.00+37% in a yearWorth $25.8B

Compare with APH · BDX · DHR · AVTR · RMD · PODD · STE

Financials, earnings and news on Stox ›
Past year

The past year

Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.

WST against the S&P 500, past year
$100 a year ago. West Pharmaceutical Services +37%, the S&P 500 +16%.
80100120140NovDecJanFebMarAprMayJunJulAugSepOct
WSTS&P 500

What kind of stock is it?

Its type on Stox Atlas, from its four scores: beating or lagging the market, a steady or erratic rank, a growing or slowing business, and whether buyers or sellers lead.

Hot Hand

BeatingErraticGrowingBought

Beating the market on a growing business with buyers adding, but its rank swings from week to week.

Hot Hand since Sep; Bellwether before that.

Also Hot Hand (59 in all): DXCM · GMED · HALO · LH · NVST · ABBV

EmbracedToppingAccumulatingRejectedStable rankBellwetherDistribution TopCoiled SpringWallflowerHolding rankFaith TradeRolling OverBottom FishedSleepy StapleUnsteady rankHot HandChurning WinnerTurning UpShow-Me GrowerBouncy rankSpeculative PopExhausted RallyFalling KnifeBroken Year

How is it doing against its group?

Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.

WST, past year+37%20 of 86 in the group
Rest of the group+20%equal-weighted
S&P 500+16%past year

West Pharmaceutical Services is +37% over the past year, against +20% for the rest of the group and +16% for the S&P 500. It ranks 20th of 86 in Health care.

100120140NovDecJanFebMarAprMayJunJulAugSepOct
WSTRest of the group

Health care on Stox ›

How much does it move?

Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.

About usual West Pharmaceutical Services typically moves 2.4% in a day, about usual for it, and it swings less than 56% of large US stocks.

Typical day2.4%about $8.81 a share
Its usual2.9%about usual, 0.8× its year’s average
Against the S&P 5002.7×the index’s typical day is 1.1%
Unusual day±4.8%twice its typical day
Deepest fall, past year−25%now 3% below its high
In the S&P’s down weeks90%of the index’s fall, three years; beta 0.8
2%3%4%NovDecJanFebMarAprMayJunJulAugSepOct
Typical daily move (ATR)Its year’s average 2.94%

WST on our dashboards

Every question where West Pharmaceutical Services appears, in the order of the home page, with its reading and place in that table. Select a question to open it with WST highlighted. Select a column to sort.

QuestionReadingPlaceDetails
Which stocks are setting new highs?
Market health
84Top23 of 311Y +37% · 3M +2% · Days at a high 6
Who reports next, and what is expected?
Earnings
62Steady101 of 106Estimate change, 1M 0% · Expected EPS growth −8% · Stock vs S&P, 1M +3.6 pts
How much do stocks move on earnings?
Earnings
95Big mover19 of 60Reports 2026-10-22 · Typical move 11.0% · Largest 33%
Which stocks are priced for perfection?
Value
88Rich45 of 60Forward P/E 37× · EV / sales 7.9× · Expected EPS growth +11%
Which companies raise their dividend every year?
Dividends and buybacks
92Decades34 of 60Years raised 33 years · Growth, 5Y +6% a yr · Yield 0.2%

Go deeper on Stox

WST’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.

How to read this page

How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.

Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.

Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.

Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.

For financial statements, earnings and news, see WST’s full profile on Stox.

This page is information, not investment advice. About our data and methods ›